계명대학교 의학도서관 Repository

박출률 감소 심부전의 치료

Metadata Downloads
Author(s)
In-Cheol Kim
Keimyung Author(s)
Kim, In Cheol
Department
Dept. of Internal Medicine (내과학)
Journal Title
대한의사협회지
Issued Date
2022
Volume
65
Issue
1
Keyword
Heart failureTherapeuticsDrug therapyHeart transplantationCardiac rehabilitation심부전치료약물치료심장이식심장재활
Abstract
Background:
Heart failure with reduced ejection fraction (HFrEF) is a syndrome consisting of typical symptoms and/or signs of heart failure (HF) due to left ventricular systolic dysfunction (ejection fraction ≤40%) caused by various underlying cardiac diseases. We report conventional and recently established pharmacologic and nonpharmacologic treatments of HFrEF in this review article.

Current Concepts:
So far, various pharmacologic treatments have been proven beneficial in reducing HF-associated hospitalization or cardiac death. The mainstay of the treatments is renin-angiotensin-aldosterone system inhibitors, which are sympathetic nervous system blockers on top of the diuretics to relieve symptoms of systemic or pulmonary congestion. Recently, new treatment targets for natriuretic peptide and sodium-glucose cotransporter have emerged in HFrEF, allowing the use of these novel drugs in addition to the optimal conventional medications. Device therapies, such as implantable cardioverter-defibrillator and cardiac resynchronization therapy, can improve the outcome in a special population. Heart transplantation is the final treatment for patients with advanced HF. However, due to the limitation of the donor pool, mechanical circulatory support is necessary.

Discussion and Conclusion:
Current guidelines recommend using the four pillars of medications in HFrEF, including angiotensin-converting enzyme inhibitors (angiotensin-neprilysin inhibitors or angiotensin receptor blockers), beta-blockers, mineralocorticoid receptor antagonists, and sodium-glucose cotransporter inhibitors. Appropriate device therapy, mechanical circulatory support, and heart transplantation can enhance survival in advanced HF patients. Balanced treatment, including conventional and newer therapies, is necessary.
Alternative Title
Treatment of heart failure with reduced ejection fraction
Keimyung Author(s)(Kor)
김인철
Publisher
School of Medicine (의과대학)
Citation
In-Cheol Kim. (2022). 박출률 감소 심부전의 치료. 대한의사협회지, 65(1), 9–17. doi: 10.5124/jkma.2022.65.1.9
Type
Article
ISSN
2093-5951
Source
https://jkma.org/journal/view.php?doi=10.5124/jkma.2022.65.1.9
DOI
10.5124/jkma.2022.65.1.9
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/44014
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.